Effects of taurine on cerulein-induced acute pancreatitis in the rat

Byung Ok Ahn, Kwang Hee Kim, Goo Lee, Hong Sik Lee, Chang Duck Kim, Young Sik Kim, Mi Won Son, Won Bae Kim, Tae Young Oh, Jin Hai Hyun

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Taurine, or 2-aminoethane sulfonic acid, is an intracellular amino acid and has been suggested to have a function in protecting biological systems from oxidative tissue damage. The aim of this study was to determine the effect of taurine against cerulein-induced acute pancreatitis in rats. Acute pancreatitis was induced by administering three subcutaneous injections of cerulein (40 μg/kg body weight) at 1-hour intervals, while taurine was administered intravenously at graded doses (30, 100, or 300 mg/kg, respectively) following the first cerulein injection. The severities of pancreatitis and lung injury were determined by measuring biochemical parameters, tissue myeloperoxidase (MPO), and histological changes. To clarify the mechanism of taurine, serum IL-1β and TNF-α levels and tissue concentrations of malondialdehyde (MDA) were evaluated. In cerulein-induced acute edematous pancreatitis, treatment with taurine significantly decreased hyperamylasemia, tissue MPO, pancreatic edema, and the extent of pancreatic and pulmonary injury. Taurine decreased MDA concentration in the pancreas and lung, but not the serum cytokine concentration. We would conclude that taurine has beneficial effects in cerulein-induced acute pancreatitis and lung injuries by preventing the production of oxygen free radicals.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalPharmacology
Volume63
Issue number1
DOIs
Publication statusPublished - 2001 Jul 19

Fingerprint

Ceruletide
Taurine
Pancreatitis
Lung Injury
Malondialdehyde
Peroxidase
Hyperamylasemia
Sulfonic Acids
Acute Lung Injury
Subcutaneous Injections
Serum
Interleukin-1
Free Radicals
Pancreas
Reactive Oxygen Species
Edema
Body Weight
Cytokines
Amino Acids
Lung

Keywords

  • Cerulein-induced pancreatitis
  • Oxygen free radical
  • Taurine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of taurine on cerulein-induced acute pancreatitis in the rat. / Ahn, Byung Ok; Kim, Kwang Hee; Lee, Goo; Lee, Hong Sik; Kim, Chang Duck; Kim, Young Sik; Son, Mi Won; Kim, Won Bae; Oh, Tae Young; Hyun, Jin Hai.

In: Pharmacology, Vol. 63, No. 1, 19.07.2001, p. 1-7.

Research output: Contribution to journalArticle

Ahn, BO, Kim, KH, Lee, G, Lee, HS, Kim, CD, Kim, YS, Son, MW, Kim, WB, Oh, TY & Hyun, JH 2001, 'Effects of taurine on cerulein-induced acute pancreatitis in the rat', Pharmacology, vol. 63, no. 1, pp. 1-7. https://doi.org/10.1159/000056106
Ahn, Byung Ok ; Kim, Kwang Hee ; Lee, Goo ; Lee, Hong Sik ; Kim, Chang Duck ; Kim, Young Sik ; Son, Mi Won ; Kim, Won Bae ; Oh, Tae Young ; Hyun, Jin Hai. / Effects of taurine on cerulein-induced acute pancreatitis in the rat. In: Pharmacology. 2001 ; Vol. 63, No. 1. pp. 1-7.
@article{8d3f089969a1435ebab8b364eaf2185c,
title = "Effects of taurine on cerulein-induced acute pancreatitis in the rat",
abstract = "Taurine, or 2-aminoethane sulfonic acid, is an intracellular amino acid and has been suggested to have a function in protecting biological systems from oxidative tissue damage. The aim of this study was to determine the effect of taurine against cerulein-induced acute pancreatitis in rats. Acute pancreatitis was induced by administering three subcutaneous injections of cerulein (40 μg/kg body weight) at 1-hour intervals, while taurine was administered intravenously at graded doses (30, 100, or 300 mg/kg, respectively) following the first cerulein injection. The severities of pancreatitis and lung injury were determined by measuring biochemical parameters, tissue myeloperoxidase (MPO), and histological changes. To clarify the mechanism of taurine, serum IL-1β and TNF-α levels and tissue concentrations of malondialdehyde (MDA) were evaluated. In cerulein-induced acute edematous pancreatitis, treatment with taurine significantly decreased hyperamylasemia, tissue MPO, pancreatic edema, and the extent of pancreatic and pulmonary injury. Taurine decreased MDA concentration in the pancreas and lung, but not the serum cytokine concentration. We would conclude that taurine has beneficial effects in cerulein-induced acute pancreatitis and lung injuries by preventing the production of oxygen free radicals.",
keywords = "Cerulein-induced pancreatitis, Oxygen free radical, Taurine",
author = "Ahn, {Byung Ok} and Kim, {Kwang Hee} and Goo Lee and Lee, {Hong Sik} and Kim, {Chang Duck} and Kim, {Young Sik} and Son, {Mi Won} and Kim, {Won Bae} and Oh, {Tae Young} and Hyun, {Jin Hai}",
year = "2001",
month = "7",
day = "19",
doi = "10.1159/000056106",
language = "English",
volume = "63",
pages = "1--7",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Effects of taurine on cerulein-induced acute pancreatitis in the rat

AU - Ahn, Byung Ok

AU - Kim, Kwang Hee

AU - Lee, Goo

AU - Lee, Hong Sik

AU - Kim, Chang Duck

AU - Kim, Young Sik

AU - Son, Mi Won

AU - Kim, Won Bae

AU - Oh, Tae Young

AU - Hyun, Jin Hai

PY - 2001/7/19

Y1 - 2001/7/19

N2 - Taurine, or 2-aminoethane sulfonic acid, is an intracellular amino acid and has been suggested to have a function in protecting biological systems from oxidative tissue damage. The aim of this study was to determine the effect of taurine against cerulein-induced acute pancreatitis in rats. Acute pancreatitis was induced by administering three subcutaneous injections of cerulein (40 μg/kg body weight) at 1-hour intervals, while taurine was administered intravenously at graded doses (30, 100, or 300 mg/kg, respectively) following the first cerulein injection. The severities of pancreatitis and lung injury were determined by measuring biochemical parameters, tissue myeloperoxidase (MPO), and histological changes. To clarify the mechanism of taurine, serum IL-1β and TNF-α levels and tissue concentrations of malondialdehyde (MDA) were evaluated. In cerulein-induced acute edematous pancreatitis, treatment with taurine significantly decreased hyperamylasemia, tissue MPO, pancreatic edema, and the extent of pancreatic and pulmonary injury. Taurine decreased MDA concentration in the pancreas and lung, but not the serum cytokine concentration. We would conclude that taurine has beneficial effects in cerulein-induced acute pancreatitis and lung injuries by preventing the production of oxygen free radicals.

AB - Taurine, or 2-aminoethane sulfonic acid, is an intracellular amino acid and has been suggested to have a function in protecting biological systems from oxidative tissue damage. The aim of this study was to determine the effect of taurine against cerulein-induced acute pancreatitis in rats. Acute pancreatitis was induced by administering three subcutaneous injections of cerulein (40 μg/kg body weight) at 1-hour intervals, while taurine was administered intravenously at graded doses (30, 100, or 300 mg/kg, respectively) following the first cerulein injection. The severities of pancreatitis and lung injury were determined by measuring biochemical parameters, tissue myeloperoxidase (MPO), and histological changes. To clarify the mechanism of taurine, serum IL-1β and TNF-α levels and tissue concentrations of malondialdehyde (MDA) were evaluated. In cerulein-induced acute edematous pancreatitis, treatment with taurine significantly decreased hyperamylasemia, tissue MPO, pancreatic edema, and the extent of pancreatic and pulmonary injury. Taurine decreased MDA concentration in the pancreas and lung, but not the serum cytokine concentration. We would conclude that taurine has beneficial effects in cerulein-induced acute pancreatitis and lung injuries by preventing the production of oxygen free radicals.

KW - Cerulein-induced pancreatitis

KW - Oxygen free radical

KW - Taurine

UR - http://www.scopus.com/inward/record.url?scp=17844392852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844392852&partnerID=8YFLogxK

U2 - 10.1159/000056106

DO - 10.1159/000056106

M3 - Article

C2 - 11408826

AN - SCOPUS:17844392852

VL - 63

SP - 1

EP - 7

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 1

ER -